List of Tables
Table 1. Non-Alcoholic Steatohepatitis Biomarkers Market Trends
Table 2. Non-Alcoholic Steatohepatitis Biomarkers Market Drivers & Opportunity
Table 3. Non-Alcoholic Steatohepatitis Biomarkers Market Challenges
Table 4. Non-Alcoholic Steatohepatitis Biomarkers Market Restraints
Table 5. Global Non-Alcoholic Steatohepatitis Biomarkers Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Non-Alcoholic Steatohepatitis Biomarkers Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Non-Alcoholic Steatohepatitis Biomarkers Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Non-Alcoholic Steatohepatitis Biomarkers Product Type
Table 9. Key Companies Time to Begin Mass Production of Non-Alcoholic Steatohepatitis Biomarkers
Table 10. Global Non-Alcoholic Steatohepatitis Biomarkers Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Alcoholic Steatohepatitis Biomarkers as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Region (2019-2024) & (%)
Table 27. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Non-Alcoholic Steatohepatitis Biomarkers Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Non-Alcoholic Steatohepatitis Biomarkers Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Non-Alcoholic Steatohepatitis Biomarkers Sales Value, (2025-2030) & (US$ Million)
Table 31. Genfit Basic Information List
Table 32. Genfit Description and Business Overview
Table 33. Genfit Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 34. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of Genfit (2019-2024)
Table 35. Genfit Recent Developments
Table 36. Prometheus Laboratories Basic Information List
Table 37. Prometheus Laboratories Description and Business Overview
Table 38. Prometheus Laboratories Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 39. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of Prometheus Laboratories (2019-2024)
Table 40. Prometheus Laboratories Recent Developments
Table 41. Siemens Medical Solutions USA Basic Information List
Table 42. Siemens Medical Solutions USA Description and Business Overview
Table 43. Siemens Medical Solutions USA Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 44. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of Siemens Medical Solutions USA (2019-2024)
Table 45. Siemens Medical Solutions USA Recent Developments
Table 46. BioPredictive Basic Information List
Table 47. BioPredictive Description and Business Overview
Table 48. BioPredictive Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 49. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of BioPredictive (2019-2024)
Table 50. BioPredictive Recent Developments
Table 51. Quest Diagnostics Basic Information List
Table 52. Quest Diagnostics Description and Business Overview
Table 53. Quest Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 54. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of Quest Diagnostics (2019-2024)
Table 55. Quest Diagnostics Recent Developments
Table 56. AstraZeneca Plc. Basic Information List
Table 57. AstraZeneca Plc. Description and Business Overview
Table 58. AstraZeneca Plc. Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 59. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of AstraZeneca Plc. (2019-2024)
Table 60. AstraZeneca Plc. Recent Developments
Table 61. Laboratory Corporation of America Holdings Basic Information List
Table 62. Laboratory Corporation of America Holdings Description and Business Overview
Table 63. Laboratory Corporation of America Holdings Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 64. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of Laboratory Corporation of America Holdings (2019-2024)
Table 65. Laboratory Corporation of America Holdings Recent Developments
Table 66. Pfizer Basic Information List
Table 67. Pfizer Description and Business Overview
Table 68. Pfizer Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 69. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of Pfizer (2019-2024)
Table 70. Pfizer Recent Developments
Table 71. Bristol-Myers Squibb Company Basic Information List
Table 72. Bristol-Myers Squibb Company Description and Business Overview
Table 73. Bristol-Myers Squibb Company Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 74. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of Bristol-Myers Squibb Company (2019-2024)
Table 75. Bristol-Myers Squibb Company Recent Developments
Table 76. NGM Biopharmaceuticals Basic Information List
Table 77. NGM Biopharmaceuticals Description and Business Overview
Table 78. NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 79. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of NGM Biopharmaceuticals (2019-2024)
Table 80. NGM Biopharmaceuticals Recent Developments
Table 81. Gilead Sciences Basic Information List
Table 82. Gilead Sciences Description and Business Overview
Table 83. Gilead Sciences Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 84. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of Gilead Sciences (2019-2024)
Table 85. Gilead Sciences Recent Developments
Table 86. Perspectum Diagnostics Basic Information List
Table 87. Perspectum Diagnostics Description and Business Overview
Table 88. Perspectum Diagnostics Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 89. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of Perspectum Diagnostics (2019-2024)
Table 90. Perspectum Diagnostics Recent Developments
Table 91. One Way Liver SL Basic Information List
Table 92. One Way Liver SL Description and Business Overview
Table 93. One Way Liver SL Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 94. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of One Way Liver SL (2019-2024)
Table 95. One Way Liver SL Recent Developments
Table 96. Enterome SA Basic Information List
Table 97. Enterome SA Description and Business Overview
Table 98. Enterome SA Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 99. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of Enterome SA (2019-2024)
Table 100. Enterome SA Recent Developments
Table 101. Echosens SA Basic Information List
Table 102. Echosens SA Description and Business Overview
Table 103. Echosens SA Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 104. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of Echosens SA (2019-2024)
Table 105. Echosens SA Recent Developments
Table 106. Cisbio Bioassays SAS Basic Information List
Table 107. Cisbio Bioassays SAS Description and Business Overview
Table 108. Cisbio Bioassays SAS Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 109. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of Cisbio Bioassays SAS (2019-2024)
Table 110. Cisbio Bioassays SAS Recent Developments
Table 111. Celerion Inc. Basic Information List
Table 112. Celerion Inc. Description and Business Overview
Table 113. Celerion Inc. Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 114. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of Celerion Inc. (2019-2024)
Table 115. Celerion Inc. Recent Developments
Table 116. Xeptagen SpA Basic Information List
Table 117. Xeptagen SpA Description and Business Overview
Table 118. Xeptagen SpA Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 119. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of Xeptagen SpA (2019-2024)
Table 120. Xeptagen SpA Recent Developments
Table 121. Boehringer Ingelheim Basic Information List
Table 122. Boehringer Ingelheim Description and Business Overview
Table 123. Boehringer Ingelheim Non-Alcoholic Steatohepatitis Biomarkers Products, Services and Solutions
Table 124. Revenue (US$ Million) in Non-Alcoholic Steatohepatitis Biomarkers Business of Boehringer Ingelheim (2019-2024)
Table 125. Boehringer Ingelheim Recent Developments
Table 126. Key Raw Materials Lists
Table 127. Raw Materials Key Suppliers Lists
Table 128. Non-Alcoholic Steatohepatitis Biomarkers Downstream Customers
Table 129. Non-Alcoholic Steatohepatitis Biomarkers Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Non-Alcoholic Steatohepatitis Biomarkers Product Picture
Figure 2. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 4. Non-Alcoholic Steatohepatitis Biomarkers Report Years Considered
Figure 5. Global Non-Alcoholic Steatohepatitis Biomarkers Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-Alcoholic Steatohepatitis Biomarkers Revenue in 2023
Figure 7. Non-Alcoholic Steatohepatitis Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Hepatic Fibrosis Biomarkers Picture
Figure 9. Serum Biomarkers Picture
Figure 10. Oxidative Stress Biomarkers Picture
Figure 11. Apoptosis Biomarkers Picture
Figure 12. Others Picture
Figure 13. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Pharmaceutical Company
Figure 17. Product Picture of Others
Figure 18. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Non-Alcoholic Steatohepatitis Biomarkers Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Non-Alcoholic Steatohepatitis Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Non-Alcoholic Steatohepatitis Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Non-Alcoholic Steatohepatitis Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Non-Alcoholic Steatohepatitis Biomarkers Sales Value (%), (2019-2030)
Figure 31. United States Non-Alcoholic Steatohepatitis Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Non-Alcoholic Steatohepatitis Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 37. China Non-Alcoholic Steatohepatitis Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 39. China Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Non-Alcoholic Steatohepatitis Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Non-Alcoholic Steatohepatitis Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Non-Alcoholic Steatohepatitis Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 49. India Non-Alcoholic Steatohepatitis Biomarkers Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Type (%), 2023 VS 2030
Figure 51. India Non-Alcoholic Steatohepatitis Biomarkers Sales Value by Application (%), 2023 VS 2030
Figure 52. Non-Alcoholic Steatohepatitis Biomarkers Industrial Chain
Figure 53. Non-Alcoholic Steatohepatitis Biomarkers Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
